Hikma Pharmaceuticals PLC Annual Report 2014 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS continued 11.
TAX CONTINUED The charge for the year can be reconciled to profit before tax per the consolidated income statement as follows: 2014 2013 $m $m Profit before tax: 362 298 Tax at the UK corporation tax rate of 21.5% 2013: 23.25% 78 69 Profits taxed at different rates 1 3 Permanent differences 8 7 Temporary differences for which no benefit is recognised 4 3 Adjustments to prior year 9 Tax expense for the year 80 82 12.
DIVIDENDS 2014 2013 $m $m Amounts recognised as distributions to equity holders in the year: Final dividend for the year ended 31 December 2013 of 13.0 cents 2012: 10.0 cents per share 25 19 Interim dividend for the year ended 31 December 2014 of 7.0 cents 2013: 7.0 cents per share 14 14 Special final dividend for the year ended 31 December 2013 of 4.0 cents 2012: nil per share 8 Special interim dividend for the year ended 31 December 2014 of 4.0 cents 2013: 3.0 cents per share 8 6 55 39 The proposed final dividend for the year ended 31 December 2014 is 15.0 cents 2013: 13.0 cents per share plus a special dividend of 6.0 cents 2013: 4.0 cents per share that reflect the exceptional performance of the Generics and Injectables businesses during the year.
This brings the full-year dividend to 22.0 cents 2013: 20.0 cents per share plus a special full-year dividend of 10.0 cents 2013: 7.0 cents per share.
The proposed final dividend is subject to approval by shareholders at the Annual General Meeting on 14 May 2015 and has not been included as a liability in these financial statements.
Based on the number of shares in issue at 31 December 2014 198,632,000, the unrecognised liability is $42 million.
EARNINGS PER SHARE Earnings per share is calculated by dividing the profit attributable to equity holders of the parent by the weighted average number of ordinary shares.
The number of ordinary shares used for the basic and diluted calculations is shown in the table below.
Adjusted basic earnings per share and adjusted diluted earnings per share are intended to highlight the adjusted results of the Group before exceptional items and intangible amortisation excluding software.
A reconciliation of the basic and adjusted earnings used is also set out below: 2014 2013 $m $m Earnings for the purposes of basic and diluted earnings per share being net profit attributable to equity holders of the parent 278 212 Exceptional items see Note 5 11 62 Intangible amortisation 14 15 Tax effect of adjustments 4 15 Adjusted earnings for the purposes of adjusted basic and diluted earnings per share being adjusted net profit attributable to equity holders of the parent 299 274 Intangible amortisation comprises the amortisation of intangible assets other than software 142
